Moreover, apart from the deleterious atherogenic effects reported in this study, genetic and pharmacological inhibition of MAGL have also been associated with a variety of beneficial effects in the treatment of pain, neuroinflammation, neurodegenerative diseases and several cancer entities [23; 33; 34]. The gene discussed is MGLL; the disease is cancer.